Back to Aberdeen Group plc Aberdeen Group plc

NAMSNAMS
Showing 8 of 9 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in NEWAMSTERDAM PHARMA COMPANY

Aberdeen Group plc holds 1.1M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), worth $37.4M as of 2026-Q2. The position was increased (+31.8% shares). NAMS represents 0.1% of Aberdeen Group plc's portfolio.

Current Value

$37.4M

Current Shares

1.1M

Total Value Change

+$35.2M

Total Shares Change

+973,725

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+31.8%
$37.4M0.1%$33.89
37
2026-Q1
Increased
837,005
+14.7%
$26.8M0.0%$30.41
33
2025-Q4
Increased
729,484
+10.2%
$25.6M0.0%$34.74
32
2025-Q3
Decreased
661,946
-9.9%
$18.8M0.0%$27.52
0
2025-Q2
Increased
735,032
+95.0%
$13.3M0.0%$18.57
45
2025-Q1
Increased
376,863
+110.5%
$7.7M0.0%$21.76
44
2024-Q4
Increased
179,060
+38.7%
$4.6M0.0%$25.60
35
2024-Q3
Increased
129,060
+69.8%
$2.1M0.0%$16.23
39

Other major holders of NAMS: Capital World Investors, FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used